Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients

• Main Authors: Federica Pigliasco (Author), Sara Malaca (Author), Alfredo Fabrizio Lo Faro (Author), Anastasio Tini (Author), Giuliana Cangemi (Author), Alessia Cafaro (Author), Sebastiano Barco (Author), Antonella Riva (Author), Angelica Pisati (Author), Elisabetta Amadori (Author), Pasquale Striano (Author), Adriano Tagliabracci (Author), Marilyn Ann Huestis (Author), Francesco Paolo Busardò (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cannabidiol (CBD) exhibits anti-inflammatory, anxiolytic, antiseizure, and neuroprotective proprieties without addictive or psychotropic side effects, as opposed to Δ9-tetrahydrocannabinol (THC). While recreational cannabis contains higher THC and lower CBD concentrations, medical cannabis contains...